Insider · CIK 0001757373
Gary S. Gillheeney
Files at ORGO (Organogenesis Holdings Inc.). First filing Dec 9, 2024, latest Dec 16, 2024.
Gary S. Gillheeney files SEC Form 4 as CEO, president and director at ORGO (Organogenesis Holdings Inc.). Since Dec 9, 2024, Gary S. Gillheeney has reported 0 open-market buys worth $0 and 3 open-market sells worth $1.4M, the latest filed on Dec 16, 2024.
A track record needs three past buys with six months of prices behind them; Gary S. Gillheeney has 0, so none is measured yet.
The newest scored trade: sold $206k of ORGO on Dec 13, 2024, filed Dec 16, 2024, scored 37 (weak).
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
ORGO: Organogenesis Holdings Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 37Weak | ORGOsell Organogenesis Holdings Inc. | $206k 61,200 shares | -2% | - | |
| 49Moderate | ORGOsell Organogenesis Holdings Inc. | $940k 259,332 shares | -8% | - | |
| 22Weak | ORGOsell Organogenesis Holdings Inc. | $212k 59,468 shares | -2% | - |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Dec 6, 2024 | ORGO Organogenesis Holdings Inc. | 380,000 0.29% of outstanding | $1.4M | Dec 6, 2024 | none |
Transactions
Every row this insider has filed, 25 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Feb 18, 2026 | ORGO Organogenesis Holdings Inc. | AGrant or award Class A Common Stock | +188,856 | $0.00 | $0 | 4,323,398 | Mar 3, 2026 |
| Feb 18, 2026 | ORGO Organogenesis Holdings Inc. | FTax withholding Class A Common Stock | -91,311 | $3.84 | $351k | 4,232,087 | Mar 3, 2026 |
| Feb 18, 2026 | ORGO Organogenesis Holdings Inc. | AGrant or award Class A Common Stock | +890,625 | $0.00 | $0 | 4,134,542 | Feb 20, 2026 |
| Feb 18, 2026 | ORGO Organogenesis Holdings Inc. | AGrant or award Class A Common Stock | +186,968 | $0.00 | $0 | 4,321,510 | Feb 20, 2026 |
| Feb 18, 2026 | ORGO Organogenesis Holdings Inc. | FTax withholding Class A Common Stock | -90,398 | $3.84 | $347k | 4,231,112 | Feb 20, 2026 |
| Feb 18, 2026 | ORGO Organogenesis Holdings Inc. | AGrant or award Stock Option (Right to Buy)derivative | +507,795 | $0.00 | $0 | 507,795 | Feb 20, 2026 |
| Feb 15, 2026 | ORGO Organogenesis Holdings Inc. | FTax withholding Class A Common Stock | -24,340 | $3.73 | $91k | 3,490,983 | Feb 18, 2026 |
| Feb 15, 2026 | ORGO Organogenesis Holdings Inc. | FTax withholding Class A Common Stock | -78,646 | $3.73 | $293k | 3,412,337 | Feb 18, 2026 |
| Feb 15, 2026 | ORGO Organogenesis Holdings Inc. | FTax withholding Class A Common Stock | -82,815 | $3.73 | $309k | 3,329,522 | Feb 18, 2026 |
| Feb 15, 2026 | ORGO Organogenesis Holdings Inc. | FTax withholding Class A Common Stock | -85,605 | $3.73 | $319k | 3,243,917 | Feb 18, 2026 |
| Feb 19, 2025 | ORGO Organogenesis Holdings Inc. | AGrant or award Class A Common Stock | +708,215 | $0.00 | $0 | 3,515,323 | Feb 21, 2025 |
| Feb 19, 2025 | ORGO Organogenesis Holdings Inc. | AGrant or award Stock Option (Right to Buy)derivative | +732,596 | $0.00 | $0 | 732,596 | Feb 21, 2025 |
| Feb 15, 2025 | ORGO Organogenesis Holdings Inc. | FTax withholding Class A Common Stock | -82,814 | $3.70 | $306k | 2,956,380 | Feb 19, 2025 |
| Feb 15, 2025 | ORGO Organogenesis Holdings Inc. | FTax withholding Class A Common Stock | -109,280 | $3.70 | $404k | 2,847,100 | Feb 19, 2025 |
| Feb 15, 2025 | ORGO Organogenesis Holdings Inc. | FTax withholding Class A Common Stock | -33,869 | $3.70 | $125k | 2,813,231 | Feb 19, 2025 |
| Feb 16, 2025 | ORGO Organogenesis Holdings Inc. | FTax withholding Class A Common Stock | -6,123 | $3.70 | $23k | 2,807,108 | Feb 19, 2025 |
| Dec 13, 2024 | ORGO Organogenesis Holdings Inc. | SOpen-market sale Class A Common Stock | -55,615 | $3.36 | $187k | 3,044,779 | Dec 16, 2024 |
| Dec 16, 2024 | ORGO Organogenesis Holdings Inc. | SOpen-market sale Class A Common Stock | -5,585 | $3.49 | $19k | 3,039,194 | Dec 16, 2024 |
| Dec 10, 2024 | ORGO Organogenesis Holdings Inc. | SOpen-market sale Class A Common Stock | -58,525 | $3.64 | $213k | 3,301,201 | Dec 12, 2024 |
| Dec 11, 2024 | ORGO Organogenesis Holdings Inc. | SOpen-market sale Class A Common Stock | -157,448 | $3.64 | $573k | 3,143,753 | Dec 12, 2024 |
| Dec 12, 2024 | ORGO Organogenesis Holdings Inc. | SOpen-market sale Class A Common Stock | -43,359 | $3.55 | $154k | 3,100,394 | Dec 12, 2024 |
| Dec 5, 2024 | ORGO Organogenesis Holdings Inc. | MOption exercise Class A Common Stock | +1,067,245 | $0.99 | $1.1M | 3,419,194 | Dec 9, 2024 |
| Dec 6, 2024 | ORGO Organogenesis Holdings Inc. | SOpen-market sale Class A Common Stock | -18,416 | $3.65 | $67k | 3,400,778 | Dec 9, 2024 |
| Dec 9, 2024 | ORGO Organogenesis Holdings Inc. | SOpen-market sale Class A Common Stock | -41,052 | $3.52 | $145k | 3,359,726 | Dec 9, 2024 |
| Dec 5, 2024 | ORGO Organogenesis Holdings Inc. | MOption exercise Stock Option (Right to Buy)derivative | -1,067,245 | $0.00 | $0 | 0 | Dec 9, 2024 |
Questions about Gary S. Gillheeney
Answered from the filings on this page, as of the latest one.
Is Gary S. Gillheeney buying or selling?
Not in the last 12 months. Gary S. Gillheeney's latest open-market trade on SEC Form 4 was sold $206k of ORGO on Dec 13, 2024.
How did Gary S. Gillheeney's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Gary S. Gillheeney has 0.
Where does Gary S. Gillheeney file Form 4?
Gary S. Gillheeney has filed Form 4 at ORGO (Organogenesis Holdings Inc.) as President and CEO. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.